Growing community of inventors

King of Prussia, PA, United States of America

Vincent J Colandrea

Average Co-Inventor Count = 8.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Vincent J ColandreaJames Francis Callahan (1 patent)Vincent J ColandreaJames Walter Janetka (31 patents)Vincent J ColandreaAnthony William James Cooper (1 patent)Vincent J ColandreaJeffrey K Kerns (1 patent)Vincent J ColandreaHong Nie (1 patent)Vincent J ColandreaNicole Cathleen Goodwin (1 patent)Vincent J ColandreaMichael Joseph Bishop (10 patents)Vincent J ColandreaKatherine Louisa Widdowson (6 patents)Vincent J ColandreaEugene L Stewart (4 patents)Vincent J ColandreaLaurel Kathryn Mcgrane (2 patents)Vincent J ColandreaChelsea Ariane Huff (1 patent)Vincent J ColandreaJoel Karpiak (1 patent)Vincent J ColandreaYuehu Li (0 patent)Vincent J ColandreaIulia Strambeanu (0 patent)Vincent J ColandreaVincent J Colandrea (1 patent)James Francis CallahanJames Francis Callahan (64 patents)James Walter JanetkaJames Walter Janetka (31 patents)Anthony William James CooperAnthony William James Cooper (19 patents)Jeffrey K KernsJeffrey K Kerns (17 patents)Hong NieHong Nie (14 patents)Nicole Cathleen GoodwinNicole Cathleen Goodwin (13 patents)Michael Joseph BishopMichael Joseph Bishop (10 patents)Katherine Louisa WiddowsonKatherine Louisa Widdowson (6 patents)Eugene L StewartEugene L Stewart (4 patents)Laurel Kathryn McgraneLaurel Kathryn Mcgrane (2 patents)Chelsea Ariane HuffChelsea Ariane Huff (1 patent)Joel KarpiakJoel Karpiak (1 patent)Yuehu LiYuehu Li (0 patent)Iulia StrambeanuIulia Strambeanu (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)

2. Fimbrion Therapeutics, Inc. (5 patents)


1 patent:

1. 11078216 - Bisaryl amides as NRF2 activators

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…